Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Ying Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2683-3321; OpenAlex author ID A5100362697. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 2 papers

Papers 7

  1. LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer. Co-author DOI 10.1038/s41418-023-01225-x↗
  2. CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. Co-author DOI 10.1038/s41467-023-41861-y↗
  3. LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling. Co-author DOI 10.1038/s41467-021-23904-4↗
  4. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1172/jci148130↗
  5. Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Co-author DOI 10.1186/s13073-021-01002-w↗
  6. GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway. Co-author DOI 10.7150/jca.38386↗
  7. Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Co-author DOI 10.1038/s41467-019-09712-x↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Zheng · 6 shared papers, 2019–2023 · strength 0.64
  2. Yanfen Zheng · 6 shared papers, 2019–2023 · strength 0.64
  3. Jiachun Su · 6 shared papers, 2019–2023 · strength 0.64
  4. Jialiang Zhang · 6 shared papers, 2019–2023 · strength 0.64
  5. Dongxin Lin · 6 shared papers, 2019–2023 · strength 0.64
  6. Xudong Huang · 5 shared papers, 2021–2023 · strength 0.58
  7. Rufu Chen · 5 shared papers, 2019–2023 · strength 0.51
  8. Lingxing Zeng · 4 shared papers, 2021–2023 · strength 0.47
  9. Shaoping Zhang · 4 shared papers, 2021–2023 · strength 0.47
  10. Junge Deng · 4 shared papers, 2021–2023 · strength 0.44
  11. Zhixiang Zuo · 4 shared papers, 2019–2023 · strength 0.40
  12. Ling Pan · 4 shared papers, 2019–2021 · strength 0.36
  13. Guandi Wu · 3 shared papers, 2021–2023 · strength 0.34
  14. Lusheng Wei · 3 shared papers, 2021 · strength 0.29
  15. Quanbo Zhou · 2 shared papers, 2023 · strength 0.28
  16. Xu Che · 3 shared papers, 2019–2021 · strength 0.26
  17. Chen Hsuan Wu · 3 shared papers, 2019–2021 · strength 0.26
  18. Rui Li · 2 shared papers, 2021–2023 · strength 0.24
  19. Chengfeng Wang · 2 shared papers, 2019–2021 · strength 0.16
  20. Rufu Chen · 1 shared paper, 2023 · strength 0.14
  21. Wei Xia · 1 shared paper, 2020 · strength 0.12
  22. Miao Zhang · 1 shared paper, 2020 · strength 0.12
  23. Chengfeng Wang · 1 shared paper, 2021 · strength 0.10
  24. Zhiqiang Fu · 1 shared paper, 2019 · strength 0.07
  25. Shengping Li · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.